Small vessel remodeling and impaired endothelial-dependent dilatation in subcutaneous resistance arteries from patients with acromegaly.

2.50
Hdl Handle:
http://hdl.handle.net/10541/53473
Title:
Small vessel remodeling and impaired endothelial-dependent dilatation in subcutaneous resistance arteries from patients with acromegaly.
Authors:
Paisley, Angela N; Izzard, A S; Gemmell, I; Cruickshank, K; Trainer, Peter J; Heagerty, A M
Abstract:
Context: Patients with acromegaly have increased morbidity and mortality, predominantly from cardiovascular disease. Hypertension and diabetes are more prevalent, both of which cause small vessel remodeling and endothelial dysfunction. Objective: To understand the structure and function of small arteries in acromegaly, subcutaneous blood vessels from gluteal fat biopsies were harvested from 18 patients with active disease (AD:56+/-15y, 14m), 23 in remission (CD:55+/-12y, 15m) and 20 healthy controls (55+/-11yrs, 10m) and examined in-vitro using pressure myography. Design: Contractile responses to cumulative noradrenaline concentrations were recorded followed by dose dependent dilator responses to acetylcholine. The acetylcholine protocol was repeated after incubation with a nitric oxide synthase inhibitor (L-NAME) and cyclooxygenase inhibitor (indomethacin). Following perfusion with Ca(2+)-free physiological saline solution, structural measurements were recorded at varying intraluminal pressures (3-180mmHg). Results: Wall thickness and wall:lumen ratio were increased in AD, reduced with treatment but remained greater in CD than controls. Wall cross-sectional area was increased in AD versus controls (P<0.001), decreased with treatment (AD vs CD: P<0.001) but remained higher than controls (CD vs controls: P=0.015). Growth index was increased in AD (20%) compared to controls (CD 9%). Contractility was similar in all groups. Endothelial-dependent dysfunction was evident in AD compared with CD (P<0.001) and controls (P<0.01). Dilation did not change following L-NAME but was impaired after indomethacin incubation. Conclusion: Active acromegaly is associated with hypertrophic remodeling of the vascular wall and embarrassed endothelial function due to reduced NO and EDHF bioavailability, both of which may contribute to the early mortality from cardiovascular disease.
Affiliation:
Department of Endocrinology, Christie Hospital, Manchester, UK; Department of Cardiovascular Medicine, Manchester Royal Infirmary, Manchester, UK; National Primary Care Research and Development Centre, University of Manchester, UK.
Citation:
Small vessel remodeling and impaired endothelial-dependent dilatation in subcutaneous resistance arteries from patients with acromegaly. 2009: J. Clin. Endocrinol. Metab.
Journal:
The Journal of Clinical Endocrinology and Metabolism
Issue Date:
27-Jan-2009
URI:
http://hdl.handle.net/10541/53473
DOI:
10.1210/jc.2008-0948
PubMed ID:
19174501
Type:
Article
Language:
en
ISSN:
0021-972X
Appears in Collections:
All Christie Publications ; Endocrinology

Full metadata record

DC FieldValue Language
dc.contributor.authorPaisley, Angela N-
dc.contributor.authorIzzard, A S-
dc.contributor.authorGemmell, I-
dc.contributor.authorCruickshank, K-
dc.contributor.authorTrainer, Peter J-
dc.contributor.authorHeagerty, A M-
dc.date.accessioned2009-03-09T16:33:19Z-
dc.date.available2009-03-09T16:33:19Z-
dc.date.issued2009-01-27-
dc.identifier.citationSmall vessel remodeling and impaired endothelial-dependent dilatation in subcutaneous resistance arteries from patients with acromegaly. 2009: J. Clin. Endocrinol. Metab.en
dc.identifier.issn0021-972X-
dc.identifier.pmid19174501-
dc.identifier.doi10.1210/jc.2008-0948-
dc.identifier.urihttp://hdl.handle.net/10541/53473-
dc.description.abstractContext: Patients with acromegaly have increased morbidity and mortality, predominantly from cardiovascular disease. Hypertension and diabetes are more prevalent, both of which cause small vessel remodeling and endothelial dysfunction. Objective: To understand the structure and function of small arteries in acromegaly, subcutaneous blood vessels from gluteal fat biopsies were harvested from 18 patients with active disease (AD:56+/-15y, 14m), 23 in remission (CD:55+/-12y, 15m) and 20 healthy controls (55+/-11yrs, 10m) and examined in-vitro using pressure myography. Design: Contractile responses to cumulative noradrenaline concentrations were recorded followed by dose dependent dilator responses to acetylcholine. The acetylcholine protocol was repeated after incubation with a nitric oxide synthase inhibitor (L-NAME) and cyclooxygenase inhibitor (indomethacin). Following perfusion with Ca(2+)-free physiological saline solution, structural measurements were recorded at varying intraluminal pressures (3-180mmHg). Results: Wall thickness and wall:lumen ratio were increased in AD, reduced with treatment but remained greater in CD than controls. Wall cross-sectional area was increased in AD versus controls (P<0.001), decreased with treatment (AD vs CD: P<0.001) but remained higher than controls (CD vs controls: P=0.015). Growth index was increased in AD (20%) compared to controls (CD 9%). Contractility was similar in all groups. Endothelial-dependent dysfunction was evident in AD compared with CD (P<0.001) and controls (P<0.01). Dilation did not change following L-NAME but was impaired after indomethacin incubation. Conclusion: Active acromegaly is associated with hypertrophic remodeling of the vascular wall and embarrassed endothelial function due to reduced NO and EDHF bioavailability, both of which may contribute to the early mortality from cardiovascular disease.en
dc.languageENG-
dc.language.isoenen
dc.subjectAcromegalyen
dc.subjectEndotheliumen
dc.subjectVasculatureen
dc.titleSmall vessel remodeling and impaired endothelial-dependent dilatation in subcutaneous resistance arteries from patients with acromegaly.en
dc.typeArticleen
dc.contributor.departmentDepartment of Endocrinology, Christie Hospital, Manchester, UK; Department of Cardiovascular Medicine, Manchester Royal Infirmary, Manchester, UK; National Primary Care Research and Development Centre, University of Manchester, UK.en
dc.identifier.journalThe Journal of Clinical Endocrinology and Metabolismen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.